Charles Holmes and Ignacio Tuduri on the Allergan AbbVie vision for the future – post-merger
Aleksandra Jones | | Interview
In May 2020 Allergan merged with AbbVie, the global research-based biopharmaceutical company. We caught up with Charles Holmes, Associate Vice President, Head of Global Marketing, Eyecare at Allergan, who is based in the UK, and Ignacio Tuduri, Vice President, Global Marketing at AbbVie, based in Chicago, Illinois, USA, to ask about the integration, their experience in the field, addressing unmet needs in ophthalmology, and current and future projects.
Read the full article now
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine